4front Ventures Corp Stock Net Asset

FFNTF Stock  USD 0.03  0.0003  0.94%   
4Front Ventures Corp fundamentals help investors to digest information that contributes to 4Front Ventures' financial success or failures. It also enables traders to predict the movement of 4Front OTC Stock. The fundamental analysis module provides a way to measure 4Front Ventures' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 4Front Ventures otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

4Front Ventures Corp OTC Stock Net Asset Analysis

4Front Ventures' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Net Asset

 = 

Current Market Value

-

Current Liabilities

More About Net Asset | All Equity Analysis

Current 4Front Ventures Net Asset

    
  255.54 M  
Most of 4Front Ventures' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 4Front Ventures Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition

Based on the recorded statements, 4Front Ventures Corp has a Net Asset of 255.54 M. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The net asset for all United States stocks is notably lower than that of the firm.

4Front Net Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 4Front Ventures' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of 4Front Ventures could also be used in its relative valuation, which is a method of valuing 4Front Ventures by comparing valuation metrics of similar companies.
4Front Ventures is currently under evaluation in net asset category among its peers.

4Front Fundamentals

About 4Front Ventures Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze 4Front Ventures Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 4Front Ventures using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 4Front Ventures Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in 4Front OTC Stock

4Front Ventures financial ratios help investors to determine whether 4Front OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 4Front with respect to the benefits of owning 4Front Ventures security.